Literature DB >> 6792583

Newborn risk factors and costs of neonatal intensive care.

C S Phibbs, R L Williams, R H Phibbs.   

Abstract

To understand the sources of the high costs of neonatal intensive care, financial and medical information on 1,185 admissions to an intensive care nursery was gathered. Multiple regression analysis showed that a significant portion of the variation in individual costs was explained by three measures of risk: low birth weight, surgical intervention, and assisted ventilation. There was a highly skewed distribution of costs. Nearly half of all admissions had none of the above risk factors, had an average cost of about $2,000, and accounted for only 13% of the total costs for the whole sample. In contrast, less than one quarter of the admissions had two or more of the risk factors, had an average cost of $19,800, and accounted for nearly 60% of the total costs. Models that predict costs and length of stay on a basis of seven risk factors were developed to allow for differences in patient populations.

Entities:  

Mesh:

Year:  1981        PMID: 6792583

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Cost effectiveness of surfactant replacement in preterm babies.

Authors:  M Mugford; S Howard
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Cost effectiveness of beractant in the prevention of respiratory distress syndrome.

Authors:  R F Soll; J Jacobs; S Pashko; R Thomas
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Home uterine activity monitoring in the prevention of very low birth weight.

Authors:  A Kempe; B P Sachs; H Ricciotti; A M Sobol; P H Wise
Journal:  Public Health Rep       Date:  1997 Sep-Oct       Impact factor: 2.792

4.  Cost implications of different approaches to the prevention of respiratory distress syndrome.

Authors:  M Mugford; J Piercy; I Chalmers
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

5.  Data analysis of the benefits of an electronic registry of information in a neonatal intensive care unit in Greece.

Authors:  Maria Skouroliakou; George Soloupis; Antonis Gounaris; Antonia Charitou; Petros Papasarantopoulos; Sophia L Markantonis; Christina Golna; Kyriakos Souliotis
Journal:  Perspect Health Inf Manag       Date:  2008-07-28

6.  The effect of telemedicine on neonatal intensive care unit length of stay in very low birthweight infants.

Authors:  M C Rendina
Journal:  Proc AMIA Symp       Date:  1998

7.  Cost of neonatal intensive care.

Authors:  R Shanmugasundaram; E Padmapriya; J Shyamala
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

8.  Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial.

Authors:  M E Backhouse; J A Mauskopf; D Jones; D E Wold; R Schumacher; R Cotton; W A Long
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

9.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

10.  Trends in mortality caused by respiratory distress syndrome in the United States, 1969-83.

Authors:  M H Malloy; R B Hartford; J C Kleinman
Journal:  Am J Public Health       Date:  1987-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.